Presentation TCT 2017 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Samir R. Kapadia, David J. Moliterno November 01, 2017
Presentation TCT 2017 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Samir R. Kapadia, Sameer Gafoor November 01, 2017
Presentation TCT 2017 Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset Presenter: Samir R. Kapadia, Brian K. Whisenant November 01, 2017
Presentation TCT 2017 Rationale and Potential Role for LAA Closure in the PCI and ACS Patient Presenter: Samir R. Kapadia, Ashish Pershad November 01, 2017
Presentation TCT 2016 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy November 01, 2016
Presentation TCT 2016 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White November 01, 2016
Presentation TCT 2016 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Martin W. Bergmann, Samir R. Kapadia, Jason H. Rogers November 01, 2016
Presentation TCT 2016 Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset Presenter: Martin W. Bergmann, Samir R. Kapadia, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient Presenter: Martin W. Bergmann, Samir R. Kapadia, Ashish Pershad November 01, 2016
Presentation TCT 2014 The Triple Therapy Conundrum: Treatment of the PCI Patient with Atrial Fibrillation Presenter: Matthew J. Price, C. Michael Gibson September 15, 2014